Clinical Trials Logo

Clinical Trial Summary

Treatment of extensive deep burn residual wounds is a common problem in burn plastic surgery. Due to bacterial invasion, excessive maturation of granulation tissue, poor abrasion resistance of new epithelium, and coexistence of wound healing and dissolution can lead to delayed wound healing. Residual wounds rarely heal spontaneously and are prone to recurrence. Mesenchymal stem cells (MSC) boost tissue repair through paracrine. Many biological effectors, including IGF-1, vascular endothelial growth factor (VEGF), TGF-β1 have been found in MSC conditioned media (MSC-CM), and play a role in promoting tissue repair and regeneration.Our previous animal experiments have confirmed the role of MSC-CM in regulating wound inflammation, repairing damaged repair cells and promoting wound regeneration. In here, we will evaluate the safety and effectiveness of mesenchymal stem cell conditioned medium-derived pleiotropic factor in treating residual burn wound.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04235296
Study type Interventional
Source Chinese PLA General Hospital
Contact Meirong Li, doctor
Phone 010-66936345
Email meirong811225@126.com
Status Recruiting
Phase Phase 1
Start date November 17, 2019
Completion date June 30, 2021